Adrenomedullin's Complex Role in Inflammation: Both Pro-Inflammatory Responder and Anti-Inflammatory Protector

Adrenomedullin rises during trauma, infection, and sepsis as both a pro-inflammatory responder and an anti-inflammatory protector, with its dual nature making it both a biomarker and potential therapeutic target.

Elsasser, Ted H et al.·Microscopy research and technique·2002·Moderate EvidenceReview
RPEP-00726ReviewModerate Evidence2002RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Adrenomedullin acts as both a pro-inflammatory stress responder and an anti-inflammatory tissue protector during disease, with its dual nature and temporal dynamics determining whether it helps or harms at each stage.

Key Numbers

How They Did This

Comprehensive review of adrenomedullin in trauma, infection, and sepsis, covering gene regulation, tissue expression, systemic effects, and interaction with inflammatory mediators.

Why This Research Matters

ADM's dual nature means simple antagonism or augmentation could backfire. Therapy must be timed and targeted to the specific phase and aspect of ADM's function — a precision medicine challenge.

The Bigger Picture

Many inflammatory mediators have dual roles — protective and harmful depending on context. ADM exemplifies this complexity and the need for precision timing in therapeutic intervention.

What This Study Doesn't Tell Us

Review synthesizing complex and sometimes contradictory data. The optimal therapeutic strategy for ADM modulation was not clearly defined.

Questions This Raises

  • ?When should ADM be boosted versus blocked?
  • ?Can ADM's anti-inflammatory effects be separated from its cardiovascular effects?
  • ?Is ADM monitoring useful for timing therapeutic interventions?

Trust & Context

Key Stat:
Dual nature ADM is both a disease fighter (anti-inflammatory) and a disease contributor (vasodilation causing hypotension) — which role dominates depends on timing
Evidence Grade:
Moderate evidence from a comprehensive review integrating molecular, cellular, and systemic ADM data across multiple disease states.
Study Age:
Published in 2002. ADM's dual role has been confirmed, and the biomarker MR-proADM is now used clinically for sepsis risk stratification.
Original Title:
Adrenomedullin has multiple roles in disease stress: development and remission of the inflammatory response.
Published In:
Microscopy research and technique, 57(2), 120-9 (2002)
Database ID:
RPEP-00726

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

Is adrenomedullin good or bad in disease?

Both, depending on timing. Early in disease, its anti-inflammatory and vasodilatory effects help protect tissues. But as disease worsens, excessive ADM can contribute to dangerous blood pressure drops and cardiovascular collapse.

How do doctors use this information?

MR-proADM (an ADM measurement) is now used in hospitals to assess sepsis severity. Understanding ADM's dual role helps doctors decide when to intervene and what to target.

Read More on RethinkPeptides

Cite This Study

RPEP-00726·https://rethinkpeptides.com/research/RPEP-00726

APA

Elsasser, Ted H; Kahl, Stas. (2002). Adrenomedullin has multiple roles in disease stress: development and remission of the inflammatory response.. Microscopy research and technique, 57(2), 120-9.

MLA

Elsasser, Ted H, et al. "Adrenomedullin has multiple roles in disease stress: development and remission of the inflammatory response.." Microscopy research and technique, 2002.

RethinkPeptides

RethinkPeptides Research Database. "Adrenomedullin has multiple roles in disease stress: develop..." RPEP-00726. Retrieved from https://rethinkpeptides.com/research/elsasser-2002-adrenomedullin-has-multiple-roles

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.